EFPIA wants to put an end to the resale of stolen and counterfeit drugs

15 September 2014

The pan-European medicines verification system that the European Federation of Pharmaceutical Industries and Associations (EFPIA) is currently implementing with all supply chain stakeholders in Europe, will put an end to the resale of stolen and counterfeit drugs in the legitimate supply chain.

Last week the Italian Medicines Agency, AIFA, reported on the latest results of its on-going investigation about stolen medicines in Italian hospitals. According to a 2014 report from Transcrime (Joint Research Center on Transnational Crime, Milan University), between 2006 and 2013, one hospital out of 10 in Italy registered thefts of pharmaceuticals.

Cooperating with all supply chain stakeholders

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK